T1	Participants 423 465	Thirty-five healthy adults age 35-69 years
T2	Participants 558 601	All participants took three gelcaps per day
T3	Participants 621 651	Nineteen participants received
T4	Participants 750 773	6 participants received
T5	Participants 1018 1103	No significant differences were detected between the treatment and the placebo groups
